Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Ana María Estrada-SánchezG V Rebec

Abstract

Abnormal electrophysiological activity in the striatum, which receives dense innervation from the cerebral cortex, is believed to set the stage for the behavioral phenotype observed in Huntington's disease (HD), a neurodegenerative condition caused by mutation of the huntingtin (mhtt) protein. However, cortical involvement is far from clear. To determine whether abnormal striatal processing can be explained by mhtt alone (cell-autonomous model) or by mhtt in the corticostriatal projection cell-cell interaction model, we used BACHD/Emx1-Cre (BE) mice, a conditional HD model in which full-length mhtt is genetically reduced in cortical output neurons, including those that project to the striatum. Animals were assessed beginning at 20 weeks of age for at least the next 40 weeks, a range over which presymptomatic BACHD mice become symptomatic. Both open-field and nest-building behavior deteriorated progressively in BACHD mice relative to both BE and wild-type (WT) mice. Neuronal activity patterns in the dorsal striatum, which receives input from the primary motor cortex (M1), followed a similar age progression because BACHD activity changed more rapidly than either BE or WT mice. However, in the M1, BE neuronal activity differed sig...Continue Reading

Citations

Aug 8, 2015·PloS One·Antonella CardinaleFrancesca R Fusco
Jul 26, 2016·Frontiers in Human Neuroscience·Kendra D Bunner, George V Rebec
Sep 8, 2016·Proceedings of the National Academy of Sciences of the United States of America·Xiaobei ZhaoWilliam C Mobley
Dec 17, 2016·Journal of Huntington's Disease·Claudia Rangel-Barajas, George V Rebec
Jul 30, 2019·Journal of Neuroscience Research·Carlos CepedaHarry V Vinters
Sep 19, 2019·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jordi Creus-Muncunill, Michelle E Ehrlich
Apr 18, 2020·PLoS Computational Biology·Adam PonziJames Kozloski
Nov 26, 2019·Cerebral Cortex·Elissa J DonzisMichael S Levine
May 1, 2019·Scientific Reports·Johanna BurgoldIrina Dudanova
Aug 17, 2016·Brain Pathology·Mar PuigdellívolEsther Pérez-Navarro
Jul 10, 2019·Annual Review of Neuroscience·C Frank BennettDon W Cleveland
Apr 6, 2018·Nucleic Acid Therapeutics·Willeke M C van Roon-MomSusanne T de Bot
Jul 25, 2018·Current Protocols in Neuroscience·Claudia Rangel-Barajas, George V Rebec
May 17, 2019·Journal of Neurochemistry·Amy I Smith-DijakLynn A Raymond
Apr 21, 2020·Journal of Huntington's Disease·Caodu BurenLynn A Raymond
Nov 18, 2020·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Carlos Cepeda, Michael S Levine
Dec 18, 2020·Neuropathology and Applied Neurobiology·Rachel Y CheongÅsa Petersén
Nov 11, 2017·Current Opinion in Neurobiology·Matthew B Veldman, X William Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.